Results for "Pain"
Conditions Encyclopedia Entry 1779373564
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. Mitochondrial Myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely, depending on the specific type of disorder and the individual affected. Common symptoms include muscle weakness, fatigue, and pain, as well as problems with vision, hearing, and balance. Mitochondrial Myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the disorder. In some cases, the disorder can be caused by a new mutation, rather than an inherited one. Diagnosis of MM typically involves a combination of genetic testing, muscle biopsy, and other medical tests. Treatment for MM is often focused on managing symptoms and improving quality of life, as there is currently no cure for the disorder. ### History/Background The first descriptions of Mitochondrial Myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production. However, it wasn't until the 1980s that the genetic basis of MM was discovered. In 1988, a team of researchers identified the first mitochondrial DNA mutation associated with a myopathic disorder. Since then, numerous other mutations have been identified, and our understanding of the genetic basis of MM has continued to grow. ### Key Information Mitochondrial Myopathies are a heterogeneous group of disorders, with over 150 different mutations identified to date. The most common types of MM include: * **Kearns-Sayre Syndrome**: a rare disorder characterized by progressive external ophthalmoplegia (PEO), muscle weakness, and cardiac conduction abnormalities. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by myoclonic seizures, muscle weakness, and ragged-red fibers on muscle biopsy. * **NARP Syndrome**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. ### Significance Mitochondrial Myopathies are a significant public health concern, affecting an estimated 1 in 5,000 people worldwide. While the disorders are rare, they can have a profound impact on the quality of life for those affected. Research into MM has also led to a greater understanding of the role of mitochondria in energy production and the development of new treatments for other disorders. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first descriptions), 1988 (identification of first mitochondrial DNA mutation) - Location: Worldwide - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Rare Diseases, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Pain, Vision Problems, Hearing Loss, Balance Disorders, Autosomal Dominant Inheritance, Maternal Inheritance, New Mutation, Genetic Testing, Muscle Biopsy, Symptom Management, Quality of Life.
Health & MedicineConditions Encyclopedia Entry 1778756960
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies (MM) are a collection of rare, inherited disorders that affect the mitochondria, the powerhouses of cells. These disorders are caused by mutations in mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including muscles, the nervous system, and other organs. Symptoms can vary widely among individuals, but often include muscle weakness, fatigue, and pain. Mitochondrial myopathies are often inherited in a maternal lineage, meaning that they are passed down from mother to child. This is because only egg cells contribute mitochondria to the fertilized egg, while sperm cells do not. As a result, mitochondrial DNA is inherited solely from the mother. The disorders can be caused by mutations in any of the 37 genes found in mitochondrial DNA, which are responsible for encoding proteins involved in energy production. ## History/Background The first reported case of mitochondrial myopathy was in 1962, when a British neurologist named Keith Killen described a family with a rare disorder affecting the muscles and nervous system. However, it wasn't until the 1980s that the genetic basis of the disorder was identified. In 1988, a team of researchers led by Douglas C. Wallace discovered that the disorder was caused by a mutation in mitochondrial DNA. This breakthrough led to a greater understanding of the role of mitochondria in human disease and paved the way for the development of new treatments. ## Key Information Mitochondrial myopathies are classified into several subtypes, including: - **Kearns-Sayre Syndrome (KSS)**: a rare disorder characterized by progressive external ophthalmoplegia (PEO), which is a weakness of the eye muscles. - **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a disorder characterized by seizures and muscle weakness. - **NARP Syndrome**: a disorder characterized by neuropathy, ataxia, and retinitis pigmentosa. - **Leigh Syndrome**: a disorder characterized by progressive brain damage and muscle weakness. Symptoms of mitochondrial myopathies can vary widely among individuals, but often include: - Muscle weakness and fatigue - Pain and stiffness in the muscles - Difficulty walking or maintaining balance - Seizures and epilepsy - Vision problems, including blindness - Hearing loss - Cognitive impairment and dementia ## Significance Mitochondrial myopathies are a significant public health concern due to their rarity and impact on affected individuals and families. While there is currently no cure for these disorders, researchers are working to develop new treatments, including gene therapy and mitochondrial-targeted antioxidants. Understanding the genetic basis of mitochondrial myopathies has also led to a greater appreciation of the importance of mitochondria in human health and disease. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Rare genetic disorders - Date: 1962 (first reported case) - Location: Worldwide - Known For: Rare inherited disorders affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Inherited Disorders, Muscle Weakness, Fatigue, Pain, Seizures, Epilepsy, Vision Problems, Hearing Loss, Cognitive Impairment.
Health & MedicineConditions Encyclopedia Entry 1776636424
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These conditions are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely, depending on the specific condition and the individual affected. Common symptoms include muscle weakness, fatigue, and pain, as well as problems with vision, hearing, and balance. Mitochondrial myopathies are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some forms of MM can be inherited in an autosomal recessive pattern, requiring two copies of the mutated gene to cause the condition. The diagnosis of MM is often challenging, as the symptoms can be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ### History/Background Mitochondrial myopathies were first described in the 1960s, but it wasn't until the 1980s that the genetic basis of these conditions was understood. The discovery of the mitochondrial DNA and its role in energy production revolutionized our understanding of these conditions. Since then, numerous studies have been conducted to better understand the causes and consequences of MM. In 1991, the first mitochondrial DNA mutation was identified as the cause of a specific form of MM. Today, over 150 different mitochondrial DNA mutations have been identified as causing MM. ### Key Information Mitochondrial myopathies are a group of rare conditions, affecting approximately 1 in 5,000 people worldwide. The most common forms of MM are: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a condition characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonic Epilepsy with Ragged-Red Fibers (MERRF)**: a condition characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsies. * **Kearns-Sayre Syndrome (KSS)**: a condition characterized by muscle weakness, heart problems, and vision loss. Other forms of MM include **Leigh Syndrome**, **NARP Syndrome**, and **Pearson Syndrome**, each with distinct symptoms and characteristics. ### Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining overall health. These conditions also underscore the importance of genetic testing and diagnosis in identifying and managing rare genetic disorders. Furthermore, research into MM has led to a greater understanding of the role of mitochondria in energy production and has implications for the treatment of various other conditions, including cancer and neurodegenerative diseases. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** First described in the 1960s - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria, leading to muscle weakness, fatigue, and other symptoms. **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Muscle Weakness, Fatigue, Pain, Vision Loss, Hearing Loss, Balance Problems, Genetic Testing, Diagnosis.
Health & MedicineConditions Encyclopedia Entry 1781151665
** **Rheumatoid Arthritis (RA)** is a chronic autoimmune disorder characterized by inflammation and degeneration of the joints, leading to pain, stiffness, and loss of function. **CONTENT:** ### Overview Rheumatoid Arthritis (RA) is a complex and multifaceted condition that affects millions of people worldwide. It is a chronic autoimmune disorder, meaning that the body's immune system mistakenly attacks the lining of the joints, leading to inflammation and degeneration. This results in pain, stiffness, and loss of function in the affected joints, which can significantly impact a person's quality of life. RA can affect any joint in the body, but it most commonly affects the hands, feet, wrists, knees, elbows, and ankles. RA is a systemic disease, meaning that it can affect not only the joints but also other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels. In severe cases, RA can lead to complications such as osteoporosis, anemia, and cardiovascular disease. While the exact cause of RA is still unknown, research suggests that a combination of genetic, environmental, and hormonal factors may contribute to its development. ### History/Background The first recorded description of RA dates back to 1800 BC, in the Ebers Papyrus, an ancient Egyptian medical text. However, it wasn't until the 19th century that RA was formally recognized as a distinct medical condition. In 1800, the British physician William Hilton described a case of "rheumatic gout," which is now recognized as RA. Over the years, our understanding of RA has evolved significantly, and it is now recognized as a complex autoimmune disorder that requires a multidisciplinary approach to treatment. ### Key Information **Key Facts:** * RA affects approximately 1% of the global population. * Women are three times more likely to develop RA than men. * The average age of diagnosis is 55-60 years old. * RA can affect any joint in the body, but it most commonly affects the hands, feet, wrists, knees, elbows, and ankles. * RA is a systemic disease, meaning that it can affect not only the joints but also other parts of the body, such as the skin, eyes, lungs, heart, and blood vessels. **Symptoms:** * Pain and stiffness in the affected joints * Swelling and redness in the affected joints * Loss of function in the affected joints * Fatigue and weakness * Weight loss * Loss of appetite **Diagnosis:** * Physical examination * Medical history * Laboratory tests (e.g., rheumatoid factor, anti-CCP antibodies) * Imaging tests (e.g., X-rays, MRI) **Treatment:** * Medications (e.g., disease-modifying antirheumatic drugs, biologics) * Physical therapy * Occupational therapy * Lifestyle modifications (e.g., exercise, diet) ### Significance RA is a significant public health concern, affecting millions of people worldwide. It is estimated that RA costs the global economy over $100 billion annually. While there is no cure for RA, early diagnosis and treatment can significantly improve outcomes and quality of life. Research into the causes and treatment of RA is ongoing, and there is hope for the development of new and more effective therapies. **INFOBOX:** - Name: Rheumatoid Arthritis - Type: Chronic autoimmune disorder - Date: 1800 BC (first recorded description) - Location: Global - Known For: Chronic inflammation and degeneration of the joints **TAGS:** Rheumatoid Arthritis, Autoimmune Disorder, Chronic Disease, Joint Inflammation, Degeneration, Pain, Stiffness, Loss of Function, Systemic Disease, Public Health Concern.
Health & MedicineConditions Encyclopedia Entry 1780479364
** **Mitochondrial Myopathies** are a group of rare genetic disorders characterized by the degeneration of muscle tissue due to impaired mitochondrial function, leading to a range of symptoms including muscle weakness, fatigue, and pain. **CONTENT:** ### Overview Mitochondrial myopathies are a complex group of disorders that affect the mitochondria, the energy-producing structures within cells. These organelles are responsible for generating energy in the form of ATP (adenosine triphosphate) through a process called oxidative phosphorylation. When the mitochondria are impaired, cells cannot produce enough energy, leading to a range of symptoms. Mitochondrial myopathies are often inherited in an autosomal dominant or mitochondrial pattern, meaning that a single copy of the mutated gene is enough to cause the condition. There are over 150 known mitochondrial myopathies, each with its unique set of symptoms and characteristics. Mitochondrial myopathies can affect any muscle group, but they often target the skeletal muscles, leading to muscle weakness, fatigue, and pain. Other symptoms may include shortness of breath, heart problems, and vision and hearing loss. The severity of the condition can vary greatly, ranging from mild to severe, and may progress over time. In some cases, mitochondrial myopathies can be life-threatening, particularly if left untreated or if the condition is severe. ### History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and fatigue. However, it wasn't until the 1980s that the genetic basis of these disorders was understood. In 1988, a team of researchers led by Dr. Doug Wallace identified the first mitochondrial DNA mutation associated with a myopathy. Since then, numerous studies have shed light on the genetic and molecular mechanisms underlying mitochondrial myopathies. ### Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA or nuclear DNA that affect the function of the mitochondria. These mutations can be inherited from one's parents or occur spontaneously. Some of the most common types of mitochondrial myopathies include: * **Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)**: a severe form of mitochondrial myopathy characterized by muscle weakness, seizures, and stroke-like episodes. * **Myoclonus Epilepsy with Ragged-Red Fibers (MERRF)**: a rare form of mitochondrial myopathy characterized by muscle weakness, seizures, and ragged-red fibers in muscle biopsies. * **Kearns-Sayre Syndrome (KSS)**: a rare form of mitochondrial myopathy characterized by muscle weakness, heart problems, and vision loss. ### Significance Mitochondrial myopathies are a significant cause of morbidity and mortality worldwide. According to the National Institutes of Health (NIH), mitochondrial myopathies affect approximately 1 in 5,000 people in the United States. While there is no cure for these disorders, various treatments are available to manage symptoms and slow disease progression. These include medications to alleviate muscle weakness and pain, as well as physical therapy and rehabilitation to improve mobility and function. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic Disorders - **Date:** 1960s (first reported cases) - **Location:** Worldwide - **Known For:** Complex group of disorders affecting mitochondrial function and leading to muscle weakness, fatigue, and pain. **TAGS:** Mitochondrial Myopathies, Genetic Disorders, Muscle Weakness, Fatigue, Pain, Mitochondrial Function, Energy Production, ATP, Oxidative Phosphorylation, Autosomal Dominant, Mitochondrial Pattern, Rare Disorders, Complex Conditions.
Health & MedicineConditions Encyclopedia Entry 1778798538
** This encyclopedia entry explores the topic of **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MMs) are a group of rare, inherited disorders that affect the mitochondria, the energy-producing structures within cells. These conditions are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. MMs primarily affect the muscles, leading to a range of symptoms, including muscle weakness, fatigue, and pain. The disorders are often characterized by a combination of muscle and neurological symptoms, and can affect individuals of all ages. Mitochondrial Myopathies are a complex and heterogeneous group of conditions, with over 150 different mutations identified. The disorders are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the condition. The severity and progression of MMs can vary widely, with some individuals experiencing mild symptoms that remain stable over time, while others may experience rapid progression and significant disability. ### History/Background The first descriptions of Mitochondrial Myopathies date back to the 1960s, when researchers began to identify cases of progressive external ophthalmoplegia (PEO), a condition characterized by weakness and paralysis of the eye muscles. In the 1980s, researchers discovered that PEO was caused by mutations in the mitochondrial DNA, leading to the identification of the first mitochondrial myopathy. Since then, numerous other mitochondrial myopathies have been identified, including Kearns-Sayre syndrome, MELAS syndrome, and myoclonic epilepsy with ragged-red fibers (MERRF). ### Key Information Mitochondrial Myopathies are characterized by a range of symptoms, including: * Muscle weakness and fatigue * Pain and stiffness in the muscles * Weakness and paralysis of the eye muscles (PEO) * Seizures and epilepsy * Hearing loss and vision loss * Cognitive impairment and dementia The disorders are often diagnosed through a combination of clinical evaluation, genetic testing, and muscle biopsy. Treatment options are limited, and typically focus on managing symptoms and slowing disease progression. In some cases, individuals with MMs may require assistive devices, such as wheelchairs or communication aids. ### Significance Mitochondrial Myopathies are a significant public health concern, affecting an estimated 1 in 5,000 individuals worldwide. The disorders are often diagnosed in childhood or adolescence, and can have a profound impact on an individual's quality of life. While there is currently no cure for MMs, research is ongoing to identify new treatments and improve our understanding of these complex disorders. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorders - **Date:** 1960s (first descriptions) - **Location:** Global - **Known For:** Complex and heterogeneous group of conditions affecting the mitochondria **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Muscle Weakness, Fatigue, Pain, Progressive External Ophthalmoplegia, Kearns-Sayre Syndrome, MELAS Syndrome, MERRF, Genetic Testing, Muscle Biopsy.
Health & MedicineConditions Encyclopedia Entry 1782947165
** This entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. **CONTENT** ### Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. Symptoms can vary widely, but often include muscle weakness, fatigue, and pain. In severe cases, mitochondrial myopathies can lead to life-threatening complications. Mitochondrial myopathies are often inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some cases may be caused by **de novo** mutations, which occur spontaneously during reproduction. The disorders are relatively rare, affecting approximately 1 in 5,000 to 1 in 10,000 people. ### History/Background The study of mitochondrial myopathies dates back to the 1960s, when researchers first identified the role of mitochondrial DNA in energy production. In the 1980s, the first cases of mitochondrial myopathies were reported, and since then, the field has grown rapidly. Today, researchers have identified over 200 different mutations that can cause mitochondrial myopathies, and new cases are being discovered regularly. ### Key Information **Key Facts:** - **Inheritance pattern:** Autosomal dominant and de novo mutations - **Prevalence:** 1 in 5,000 to 1 in 10,000 people - **Symptoms:** Muscle weakness, fatigue, pain, and other systemic symptoms - **Causes:** Mutations in mitochondrial DNA - **Treatment:** No cure, but various treatments can manage symptoms **Key Achievements:** - **Identification of mitochondrial DNA:** 1960s - **First cases reported:** 1980s - **Discovery of over 200 mutations:** 1990s-present ### Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in overall health. The disorders also underscore the need for further research into the causes and treatment of rare genetic conditions. Additionally, mitochondrial myopathies have implications for our understanding of aging and age-related diseases, as the mitochondria play a critical role in energy production and cellular maintenance. **INFOBOX** - **Name:** Mitochondrial Myopathies - **Type:** Rare genetic disorder - **Date:** 1960s (first identified), 1980s (first cases reported) - **Location:** Global - **Known For:** Rare genetic disorders affecting mitochondrial function **TAGS:** Mitochondrial Myopathies, Rare Genetic Disorders, Mitochondrial DNA, Energy Production, Muscle Weakness, Fatigue, Pain, Autosomal Dominant Inheritance, De Novo Mutations, Aging, Age-Related Diseases.